Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Welt, Corrine K ^a   Styrkarsdottir, Unnur ^b   Ehrmann, David A ^d   Thorleifsson, Gudmar ^b   Arason, Gudmundur ^b   Gudmundsson, Jens A ^c   Ober, Carole ^d   Rosenfield, Robert L ^d   Saxena, Richa ^a   Thorsteinsdottir, Unnur ^b   Crowley, William F ^a   Stefansson, Kari ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ICELAND   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHINESE; CHROMOSOME 9P; CHROMOSOME REPLICATION; CONTROLLED STUDY; DENND1A GENE; EUROPE; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HYPERANDROGENISM; ICELAND; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PLESIOMORPHY; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; MUTATION; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84863593326     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3478     Document Type: Article

References (20)

1. 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
2. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
3. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of noninsulin-dependent diabetes mellitus. J Clin Invest 96:520-527
4. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146 (Pubitemid 29028311)
5. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI 2006 Heritability of polycystic ovary syndrome (PCOS) in a Dutch twin-family study. J Clin Endocrinol Metab 91:2100-2104 (Pubitemid 43854989)
6. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J, Liang X, Zhao X, Zhao J, Sun Y, Zhang B, Jiang H, Zhao D, Bian Y, Gao X, Geng L, Li Y, Zhu D, Sun X, Xu JE, Hao C, Ren CE, Zhang Y, Chen S, Zhang W, Yang A, Yan J, Li Y, Ma J, Zhao Y 2011 Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43:55-59
7. Goodarzi MO, Jones MR, Li X, Chua AK, Garcia OA, Chen YD, Krauss RM, Rotter JI, Ankener W, Legro RS, Azziz R, Strauss 3rd JF, Dunaif A, Urbanek M 2012 Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet 49:90-95
8. Lerchbaum E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B 2011 Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women. Horm Metab Res 43:743-747
9. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF 2006 Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam Criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 91:4842-4848 (Pubitemid 44917316)
10. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
11. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdóttir H, Gudlaugsdóttir G, Ingadóttir G, Crowley WF 2006 Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 91:4361-4368 (Pubitemid 44833410)
12. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 91:48-53 (Pubitemid 43069116)
13. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske Jr RF, Nicolae DL, Elias JA, Chupp GL 2008 Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358:1682-1691 (Pubitemid 351549915)
14. 1000 Genomes Project Consortium 2010 A map of human genome variation from population-scale sequencing. Nature 467:1061-1073
15. Kong A, Masson G, Frigge ML, Gylfason A, Zusmanovich P, Thorleifsson G, Olason PI, Ingason A, Steinberg S, Rafnar T, Sulem P, Mouy M, Jonsson F, Thorsteinsdottir U, Gudbjartsson DF, Stefansson H, Stefansson K 2008 Detection of sharing by descent, long-range phasing, and haplotype imputation. Nat Genet 40:1068-1075
16. Kutyavin IV, Milesi D, Belousov Y, Podyminogin M, Vorobiev A, Gorn V, Lukhtanov EA, Vermeulen NM, Mahoney W 2006 A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res 34:e128
17. Marchini J, Howie B, Myers S, McVean G, Donnelly P 2007 A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39:906-913 (Pubitemid 47014502)
18. Mantel N, Haenszel W 1959 Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
19. Marat AL, Dokainish H, McPherson PS 2011 DENN domain proteins: regulators of Rab GTPases. J Biol Chem 286:13791-13800
20. Tasaka K, Masumoto N, Mizuki J, Ikebuchi Y, Ohmichi M, Kurachi H, Miyake A, Murata Y 1998 Rab3B is essential for GnRH-induced gonadotrophin release from anterior pituitary cells. J Endocrinol 157:267-274 (Pubitemid 28238030)